Apixaban ( Eliquis) ATI medication template - Studocu
Tanya Young Apixaban ( Eliquis) anticoagulants Acts as a selective, reversible site inhibitor of factor Xa, inhibiting both free and bound factor. Does not affect platelet aggregation directly, but does inhibit thrombin-induced platelet aggregation.
- 评论数: 14
ELIQUIS is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. ELIQUIS can cause serious,...
Apixaban template - ACTIVE LEARNING TEMPLATES …
Sydney Sather Apixaban factor xa inhibitors. Acts as a selective, reversible site inhibitor of factor Xa, inhibiting both free and bound factor. Does not affect platelet aggregation directly, but does inhibit thrombin-induced platelet aggregation. Decreases …
Apixaban (Eliquis) med template - ACTIVE LEARNING TEMPLATES …
On Studocu you find all the lecture notes, summaries and study guides you need to pass your exams with better grades.
ATI-active medication template apixaban.pdf - Course Hero
2020年2月27日 · Apixaban should be avoided St. John's wort can decrease levevls and increase risk of thromboses End of preview. Upload your study docs or become a member. View full document. Unformatted text preview: and should be avoided. Previous severe hypersensitivity reactions, severe hepatic impairment Antidote or reversal agent is not available. ...
- 评论数: 13
The recommended dose of apixaban is 2.5 mg taken orally twice daily in patients with NVAF and at least two of the following characteristics: age ≥ 80 years, body weight ≤ 60 kg, or serum creatinine ≥ 1.5 mg/dL (133
Anticoagulant Medication Template: Apixaban (Eliquis) Dosage ...
2024年6月30日 · View Apixaban.docx from MEDICAL TR 258 at Centennial College. COMMON MEDICATION TEMPLATE - one medication per page, 25 words or less Drug - Generic, Apixaban Trade
Apixaban also demonstrates anti-FXa activity as evident by reduction in FXa enzyme activity in the Rotachrom® Heparin chromogenic assay. The relationship between apixaban plasmaconcentration and anti-FXa activity is linear over a wide dose range of apixaban, and precision of the Rotachrom® assay is
Apixaban ( Eliquis) - ATI Medication Templates - Studocu
Assess patient for symptoms of stroke, DVT, PE, bleeding, or peripheral vascular disease periodically during therapy. Reduction in the risk and treatment of stroke and systemic embolism. Instruct patient to take apixaban as directed. Take missed doses as soon as remembered on the same day and resume twice daily administration; do not double doses.
- 评论数: 26
ELIQUIS is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. ELIQUIS is indicated for the prophylaxis of deep vein thrombosis (DVT),...